User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 19 results.
    • Journal article
    Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact.
    Honoré, Natasha[UCL] Galot, Rachel[UCL] van Marcke, Cédric[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2021) Cancers — Vol. 13, no. 21, p. 5364 [1-25] (2021)
    • Dissertation
    Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck
    Galot, Rachel[UCL] (2020)
    • Journal article
    Unusual presentation of bladder cancer resurgence and efficacy of radiotherapy.
    Galot, Rachel[UCL] Christian, Nicolas Bitar, Marie Seront, Emmanuel (2016) BMJ case reports — Vol. 2016 (2016)
    • Journal article
    Characterization of the immune microenvironment of recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) that progress on or after platinum and anti-PD(L)1 therapies: An EORTC IMMUcan sub-project
    van der Elst, Athénaïs[UCL] Herrero Saboya, Daniel Morfouace, Marie Galot, Rachel[UCL] van Marcke, Cédric[UCL] Lucas, S.[UCL] Machiels, Jean-Pascal[UCL] (2022) Immuno-Oncology and Technology — Vol. 16, p. 100317 (2022)
    • Journal article
    Safety of drug treatments for head and neck cancer
    Galot, Rachel[UCL] Machiels, Jean-Pascal[UCL] (2016) Expert Opinion on Drug Safety — Vol. 15, no.11, p. 1527-1539 (2016)
    • Speech
    A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic(RM) squamous cell carcinoma of the head and neck (SCCHN): result s of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM.
    Galot, Rachel[UCL] (2023) ESMO 2023 — Madrid
    • Speech
    Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
    Honoré, Natasha[UCL] van Marcke, Cédric[UCL] Galot, Rachel[UCL] Helaers, Raphaël[UCL] Van Maanen, Aline[UCL] Ambroise, Jérôme[UCL] Mendola, Antonella[UCL] Dahou, Hajar[UCL] Marbaix, Etienne[UCL] Van Eeckhout, Pascal[UCL] longton, Eléonore[UCL] Magremanne, Michèle[UCL] Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2023) ESMO Congress 2023 — Madrid
    • Journal article
    HER2 and HER3 in HPV+ and HPV- HNSCC--Letter.
    Machiels, Jean-Pascal[UCL] Galot, Rachel[UCL] Schmitz, Sandra[UCL] (2016) Clinical Cancer Research — Vol. 22, no.7, p. 1825 (2016)
    • Speech
    Liquid biopsy for mutational profiling of locoregional recurrent (LR) and/or metastatic (M) squamous cell carcinoma of the head and neck (SCCHN)
    Galot, Rachel[UCL] van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] Mendola, Antonella[UCL] Goebbels, Rose-Marie[UCL] Caignet, Xavier[UCL] Ambroise, Jérôme[UCL] Wittouck, Kyril[UCL] Vikkula, Miikka[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2019) ESMO — Barcelona
    • Speech
    Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
    Galot, Rachel[UCL] (2023) ASCO 2023 — Chicago
    • Journal article
    Current applications and challenges of circulating tumor DNA (ctDNA)in squamous cell carcinoma of the head and neck
    Galot, Rachel[UCL] Machiels, Jean-Pascal[UCL] (2020) Cancer treatment reviews — Vol. 85, p. 101992 [1-13] (2020)
    • Journal article
    A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
    Galot, Rachel[UCL] Le Tourneau, Christophe Saada-Bouzid, Esma Daste, Amaury Even, Caroline Debruyne, Philip Henry, Stéphanie[UCL] Zanetta, Sylvie Rutten, Anemie Licitra, Lisa Canon, Jean-Luc Kaminsky, Marie-Christine Specenier, Pol Rottey, Sylvie Guigay, Joël Kong, Anthony Tinhofer, Inge Borcoman, Edith Dirix, Lieve Raveloarivahy, Tiana Fortpied, Catherine Vanlancker, Maureen Morfouace, Marie Govaerts, Anne-Sophie Machiels, Jean-Pascal[UCL] (2021) European journal of cancer — Vol. 158, p. 17-26 (2021)
    • Speech
    A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
    Galot, Rachel[UCL] Le Tourneau, C Saada-Bouzid, E Daste, A Even, C Debruyne, P Henry, S Zanetta, S Rutten, A Licitra, L Canon, JL Kaminsky, MC Specenier, P Rottey, S Dirix, L Raveloarivahy, T Fortpied, C Vanlancker, M Govaerts, A Machiels, Jean-Pascal[UCL] (2019) ESMO annual congress 2019 — (Sapin) Barcelona
    • Journal article
    Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma.
    Galot, Rachel[UCL] van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] Mendola, Antonella[UCL] Goebbels, Rose-Marie[UCL] Caignet, Xavier[UCL] Ambroise, Jérôme[UCL] Wittouck, Kyril[UCL] Vikkula, Miikka[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2020) Oral oncology — Vol. 104, p. 104631 (2020)
    • Journal article
    Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.
    Galot, Rachel[UCL] Le Tourneau, Christophe Guigay, Joël Licitra, Lisa Tinhofer, Inge Kong, Anthony Caballero, Carmelia Fortpied, Catherine Bogaerts, Jan Govaerts, Anne-Sophie Staelens, Dominiek Raveloarivahy, Tiana Rodegher, Luciana Laes, Jean-François Saada-Bouzid, Esma Machiels, Jean-Pascal[UCL] (2018) Annals of oncology : official journal of the European Society for Medical Oncology — Vol. 29, no. 12, p. 2313-2327 (2018)
    • Journal article
    Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case
    Pierrard, Julien[UCL] Seront, Emmanuel[UCL] Galot, Rachel[UCL] Gunes Tatar, Idil[UCL] Baurain, Jean-François[UCL] Di Perri, Dario[UCL] (2023) Acta Clinica Belgica — Vol. 78, no. 6, p. 516-520 (2023)
    • Journal article
    Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
    van Marcke, Cédric[UCL] Honoré, Natasha[UCL] van der Elst, Athénaïs[UCL] Beyaert, Simon[UCL] Derouane, Françoise[UCL] Dumont, Caroline[UCL] Aboubakar Nana, Frank[UCL] Baurain, Jean-François[UCL] Borbath, Ivan[UCL] Collard, Philippe[UCL] Cornelis, Frank[UCL] De Cuyper, Astrid[UCL] Duhoux, Francois[UCL] Filleul, Bertrand Galot, Rachel[UCL] Gizzi, Marco[UCL] Mazzeo, Filomena[UCL] Pieters, Thierry[UCL] Seront, Emmanuel[UCL] Sinapi, Isabelle[UCL] Van Den Eynde, Marc[UCL] Whenham, Nicolas Yombi, Jean Cyr[UCL] Scohy, Anaïs[UCL] van Maanen, Aline[UCL] Machiels, Jean-Pascal[UCL] (2021) BMC cancer — Vol. 21, no.1, p. 578 [1-12] (2021)
    • Journal article
    Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor.
    Honoré, Natasha[UCL] van der Elst, Athénaïs[UCL] Dietz, Anna[UCL] van Marcke, Cédric[UCL] Helaers, Raphaël[UCL] Mendola, Antonella[UCL] Dahou, Hajar[UCL] Marbaix, Etienne[UCL] Poncin, Renaud Seront, Emmanuel[UCL] Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Galot, Rachel[UCL] Machiels, Jean-Pascal[UCL] (2023) European journal of cancer — Vol. 195, p. 113372 [1-8] (2023)
    • Journal article
    Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck
    Honoré, Natasha[UCL] van Marcke, Cédric[UCL] Galot, Rachel[UCL] Helaers, Raphaël[UCL] Van Maanen, Aline[UCL] Ambroise, Jérôme[UCL] Mendola, Antonella[UCL] Dahou, Hajar[UCL] Marbaix, Etienne[UCL] van Eeckhout, Pascal[UCL] Longton, Eléonore[UCL] Magremanne, Michèle[UCL] Schmitz, Sandra[UCL] Limaye, Nisha[UCL] Machiels, Jean-Pascal[UCL] (2023) Annals of oncology — Vol. 34, no. 12, p. 1175-1186 (2023)